Efficacy and Safety of Immune Checkpoint Inhibitors (ICI) in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis

被引：0
|
作者：
Xiao, T. [1 ]
Verma, S. [1 ]
Boldt, G. [1 ]
Rajeh, A. [1 ]
Breadner, D. [2 ]
Raphael, J. [3 ]
机构：
[1] Western Univ, London, ON, Canada
[2] LRCP, London, ON, Canada
[3] Western Univ, London Hlth Sci Ctr, London, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
103
引用
收藏
页码：E6 / E6
页数：1
相关论文
共 50 条
  • [41] Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for Resectable Non-small Cell Lung Cancer: a Systematic Review and Network Meta-analysis
    Mei, T.
    Zhou, Q.
    Gong, Y.
    CLINICAL ONCOLOGY, 2024, 36 (02) : 107 - 118
  • [42] Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis
    Li Yan
    Liang Xueyan
    Li Huijuan
    Chen Xiaoyu
    中华医学杂志(英文版), 2023, 136 (18)
  • [43] Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis
    Li, Yan
    Liang, Xueyan
    Li, Huijuan
    Chen, Xiaoyu
    CHINESE MEDICAL JOURNAL, 2023, 136 (18) : 2156 - 2165
  • [44] Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis
    Cui, Ran
    Li, Yun
    Yu, Xinlin
    Wei, Chun
    Jiang, Ou
    PLOS ONE, 2024, 19 (06):
  • [45] Efficacy and safety of neoadjuvant immunotherapy in non-small cell lung cancer: a systematic review and meta-analysis
    Xu, Ke
    Ni, Juan
    Wu, Xiaodi
    Xie, Jingyuan
    Chen, Mo
    Zhang, Fang
    Liu, Hongbing
    Zhan, Ping
    Lv, Tangfeng
    Song, Yong
    AME MEDICAL JOURNAL, 2022, 7
  • [46] Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis
    Olivares-Hernandez, Alejandro
    Roldan-Ruiz, Jonnathan
    Miramontes-Gonzalez, Jose Pablo
    Toribio-Garcia, Irene
    Garcia-Hernandez, Juan Luis
    Posado-Dominguez, Luis
    Bellido-Hernandez, Lorena
    Cruz-Hernandez, Juan Jesus
    Fonseca-Sanchez, Emilio
    del Barco-Morillo, Edel
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (06)
  • [47] Prediction accuracy of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis
    Zhuang, Wei
    Zhao, Jie
    Sun, Boyang
    Bai, Hua
    Wang, Zhijie
    Zhong, Jia
    Wan, Rui
    Liu, Lihui
    Duan, Jianchun
    Wang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Immune Checkpoint Inhibitors with or without Radiotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis
    Kim, Dong Yeong
    Kim, Pyeong Hwa
    Suh, Chong Hyun
    Kim, Kyung Won
    Kim, Ho Sung
    DIAGNOSTICS, 2020, 10 (12)
  • [49] Efficacy and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis
    Zeng, Tianni
    Fang, Xiaojie
    Lu, Jinhua
    Zhong, Yazhen
    Lin, Xianlei
    Lin, Zechen
    Wang, Nan
    Jiang, Jing
    Lin, Shengyou
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (01) : 251 - 258
  • [50] Efficacy and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis
    Tianni Zeng
    Xiaojie Fang
    Jinhua Lu
    Yazhen Zhong
    Xianlei Lin
    Zechen Lin
    Nan Wang
    Jing Jiang
    Shengyou Lin
    International Journal of Colorectal Disease, 2022, 37 : 251 - 258
12345